{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:02:42Z","timestamp":1789419762165,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100017693","name":"Guilin Science and Technology Bureau","doi-asserted-by":"publisher","award":["20210227-10-12"],"award-info":[{"award-number":["20210227-10-12"]}],"id":[{"id":"10.13039\/501100017693","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"DOI":"10.1186\/s13148-025-02003-x","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T16:20:48Z","timestamp":1763137248000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Molecular mechanisms by which C1orf112 promotes endometrial cancer progression and the development and validation of a clinical scoring model"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1564-6416","authenticated-orcid":false,"given":"Lan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siling","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9500-6055","authenticated-orcid":false,"given":"Liangdan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"issue":"3","key":"2003_CR1","doi-asserted-by":"publisher","first-page":"304.e1","DOI":"10.1016\/j.ajog.2024.08.028","volume":"232","author":"E Kivek\u00e4s","year":"2025","unstructured":"Kivek\u00e4s E, et al. Robotic-assisted versus conventional laparoscopic surgery for endometrial cancer: long-term results of a randomized controlled trial. Am J Obstet Gynecol. 2025;232(3):304.e1-304.e8.","journal-title":"Am J Obstet Gynecol"},{"key":"2003_CR2","doi-asserted-by":"crossref","unstructured":"Cooley V, et al. Prospective evaluation of 92 protein biomarkers for early detection of endometrial cancer. Int J Cancer. 2025 Aug 1. null.","DOI":"10.1002\/ijc.35428"},{"key":"2003_CR3","doi-asserted-by":"publisher","first-page":"1560625","DOI":"10.3389\/fonc.2025.1560625","volume":"15","author":"Y Yuan","year":"2025","unstructured":"Yuan Y, et al. Single-cell sequencing reveals the role of aggrephagy-related patterns in tumor microenvironment, prognosis and immunotherapy in endometrial cancer. Front Oncol. 2025;15:1560625.","journal-title":"Front Oncol"},{"issue":"5","key":"2003_CR4","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.3802\/jgo.2025.36.e77","volume":"36","author":"T Kakuwa","year":"2025","unstructured":"Kakuwa T, et al. Quality indicators for endometrial cancer care in Japan. J Gynecol Oncol. 2025;36(5):e77.","journal-title":"J Gynecol Oncol"},{"issue":"9","key":"2003_CR5","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1200\/JCO.24.01121","volume":"43","author":"DE Matei","year":"2025","unstructured":"Matei DE, et al. Long-term follow-up and overall survival in NRG258, a randomized phase III trial of chemoradiation versus chemotherapy for locally advanced endometrial carcinoma. J Clin Oncol. 2025;43(9):1055\u201360.","journal-title":"J Clin Oncol"},{"key":"2003_CR6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ygyno.2022.11.012","volume":"168","author":"\u00c5 \u00c5kesson","year":"2023","unstructured":"\u00c5kesson \u00c5, Adok C, Dahm-K\u00e4hler P. Recurrence and survival in endometrioid endometrial cancer - a population-based cohort study. Gynecol Oncol. 2023;168:127\u201334.","journal-title":"Gynecol Oncol"},{"key":"2003_CR7","doi-asserted-by":"publisher","first-page":"1500658","DOI":"10.3389\/fonc.2024.1500658","volume":"14","author":"Z Huang","year":"2024","unstructured":"Huang Z, Li X, Li L. Early recurrence after surgery in FIGO 2023 stage I-III endometrial cancer: characteristics and risk factors. Front Oncol. 2024;14:1500658.","journal-title":"Front Oncol"},{"key":"2003_CR8","doi-asserted-by":"publisher","first-page":"102790","DOI":"10.1016\/j.ctrv.2024.102790","volume":"129","author":"A Salmon","year":"2024","unstructured":"Salmon A, et al. Locally advanced and metastatic endometrial cancer: current and emerging therapies. Cancer Treat Rev. 2024;129:102790.","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"2003_CR9","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1080\/13696998.2024.2403278","volume":"27","author":"SJ Lubinga","year":"2024","unstructured":"Lubinga SJ, et al. Budget impact of dostarlimab plus carboplatin-paclitaxel for primary advanced or recurrent endometrial cancer from a third-party US payer perspective. J Med Econ. 2024;27(1):1212\u201321.","journal-title":"J Med Econ"},{"issue":"5","key":"2003_CR10","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1111\/cas.70015","volume":"116","author":"Y Yang","year":"2025","unstructured":"Yang Y, et al. Transferrin receptor promotes endometrial cancer proliferation by activating the iron-dependent PI3K\/AKT\/mTOR signaling pathway. Cancer Sci. 2025;116(5):1352\u201365.","journal-title":"Cancer Sci"},{"key":"2003_CR11","doi-asserted-by":"crossref","unstructured":"Ambrosini M, et al. Epidemiology, pathogenesis, biology and evolving management of MSI-H\/dMMR cancers. Nat Rev Clin Oncol, 2025. null.","DOI":"10.1038\/s41571-025-01015-z"},{"key":"2003_CR12","doi-asserted-by":"crossref","unstructured":"Asif H, Kim JJ. Comparing self\u2010reported race and genetic ancestry for identifying potential differentially methylated sites in endometrial cancer: insights from African ancestry proportions using machine learning models. Mol Oncol. 2025 Mar 6. null.","DOI":"10.1002\/1878-0261.70013"},{"issue":"1","key":"2003_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.21037\/cco-23-139","volume":"13","author":"L Liu","year":"2024","unstructured":"Liu L, et al. Bioinformatics identification of characteristic genes of cervical cancer via an artificial neural network. Chin Clin Oncol. 2024;13(1):4.","journal-title":"Chin Clin Oncol"},{"issue":"10","key":"2003_CR14","doi-asserted-by":"publisher","first-page":"6050","DOI":"10.21037\/tcr-20-704","volume":"9","author":"X Xia","year":"2020","unstructured":"Xia X, Li Y. Comprehensive analysis of transcriptome data stemness indices identifies key genes for controlling cancer stem cell characteristics in gastric cancer. Transl Cancer Res. 2020;9(10):6050\u201361.","journal-title":"Transl Cancer Res"},{"issue":"12","key":"2003_CR15","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1111\/iju.15276","volume":"30","author":"HQ Liang","year":"2023","unstructured":"Liang HQ, et al. Identification of tumor immunophenotypes associated with immunotherapy response in bladder cancer. Int J Urol. 2023;30(12):1122\u201332.","journal-title":"Int J Urol"},{"issue":"D1","key":"2003_CR16","doi-asserted-by":"publisher","first-page":"D956","DOI":"10.1093\/nar\/gkx1090","volume":"46","author":"SV Vasaikar","year":"2018","unstructured":"Vasaikar SV, et al. Linkedomics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res. 2018;46(D1):D956\u201363.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"2003_CR17","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.7150\/ijbs.102079","volume":"21","author":"X Shen","year":"2025","unstructured":"Shen X, et al. High-dose ascorbate exhibits anti-proliferative and anti-invasive effects dependent on PTEN\/AKT\/mTOR pathway in endometrial cancer in vitro and in vivo. Int J Biol Sci. 2025;21(4):1545\u201365.","journal-title":"Int J Biol Sci"},{"key":"2003_CR18","doi-asserted-by":"publisher","first-page":"710944","DOI":"10.3389\/fgene.2021.710944","volume":"12","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, et al. High expression of C1ORF112 predicts a poor outcome: a potential target for the treatment of low-grade gliomas. Front Genet. 2021;12:710944.","journal-title":"Front Genet"},{"key":"2003_CR19","doi-asserted-by":"publisher","first-page":"693651","DOI":"10.3389\/fmolb.2021.693651","volume":"8","author":"J Chen","year":"2021","unstructured":"Chen J, et al. Pan-cancer analysis identified C1ORF112 as a potential biomarker for multiple tumor types. Front Mol Biosci. 2021;8:693651.","journal-title":"Front Mol Biosci"},{"key":"2003_CR20","doi-asserted-by":"publisher","first-page":"570702","DOI":"10.3389\/fmolb.2020.570702","volume":"7","author":"X Chen","year":"2020","unstructured":"Chen X, et al. Prognostic prediction using a stemness index-related signature in a cohort of gastric cancer. Front Mol Biosci. 2020;7:570702.","journal-title":"Front Mol Biosci"},{"issue":"5","key":"2003_CR21","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.molcel.2022.12.033","volume":"83","author":"MJ Cuneo","year":"2023","unstructured":"Cuneo MJ, et al. Higher-order SPOP assembly reveals a basis for cancer mutant dysregulation. Mol Cell. 2023;83(5):731-745.e4.","journal-title":"Mol Cell"},{"issue":"9","key":"2003_CR22","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.1007\/s00018-021-03789-8","volume":"78","author":"J Edogbanya","year":"2021","unstructured":"Edogbanya J, et al. Evolution, structure and emerging roles of C1ORF112 in DNA replication, DNA damage responses, and cancer. Cell Mol Life Sci. 2021;78(9):4365\u201376.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"2003_CR23","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1186\/s12967-025-06449-8","volume":"23","author":"J Liu","year":"2025","unstructured":"Liu J, et al. Cold atmospheric plasma drives USP49\/HDAC3 axis mediated ferroptosis as a novel therapeutic strategy in endometrial cancer via reinforcing lactylation dependent p53 expression. J Transl Med. 2025;23(1):442.","journal-title":"J Transl Med"},{"key":"2003_CR24","doi-asserted-by":"publisher","first-page":"984714","DOI":"10.3389\/fgene.2022.984714","volume":"13","author":"LM Hu","year":"2022","unstructured":"Hu LM, Ou XH, Shi SY. A comprehensive analysis of G-protein-signaling modulator 2 as a prognostic and diagnostic marker for pan-cancer. Front Genet. 2022;13:984714.","journal-title":"Front Genet"},{"issue":"7","key":"2003_CR25","doi-asserted-by":"publisher","first-page":"112668","DOI":"10.1016\/j.celrep.2023.112668","volume":"42","author":"C Stok","year":"2023","unstructured":"Stok C, et al. FIRRM\/C1orf112 is synthetic lethal with PICH and mediates RAD51 dynamics. Cell Rep. 2023;42(7):112668.","journal-title":"Cell Rep"},{"issue":"4","key":"2003_CR26","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1093\/jnci\/djad008","volume":"115","author":"M Sun","year":"2023","unstructured":"Sun M, et al. Metabolically (un)healthy obesity and risk of obesity-related cancers: a pooled study. J Natl Cancer Inst. 2023;115(4):456\u201367.","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"2003_CR27","doi-asserted-by":"publisher","first-page":"112907","DOI":"10.1016\/j.celrep.2023.112907","volume":"42","author":"Z Zhou","year":"2023","unstructured":"Zhou Z, et al. C1orf112 teams up with FIGNL1 to facilitate RAD51 filament disassembly and DNA interstrand cross-link repair. Cell Rep. 2023;42(8):112907.","journal-title":"Cell Rep"},{"issue":"1","key":"2003_CR28","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/s41467-024-45139-9","volume":"15","author":"JD Tischler","year":"2024","unstructured":"Tischler JD, et al. FLIP(C1orf112)-FIGNL1 complex regulates RAD51 chromatin association to promote viability after replication stress. Nat Commun. 2024;15(1):866.","journal-title":"Nat Commun"},{"issue":"4","key":"2003_CR29","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41419-024-06564-2","volume":"15","author":"B Wang","year":"2024","unstructured":"Wang B, et al. LIN28B induced PCAT5 promotes endometrial cancer progression and glycolysis via IGF2BP3 deubiquitination. Cell Death Dis. 2024;15(4):242.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2003_CR30","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.eururo.2016.04.028","volume":"71","author":"Y Li","year":"2017","unstructured":"Li Y, et al. SRRM4 drives neuroendocrine transdifferentiation of prostate adenocarcinoma under Androgen Receptor pathway inhibition. Eur Urol. 2017;71(1):68\u201378.","journal-title":"Eur Urol"},{"issue":"8","key":"2003_CR31","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/nsmb961","volume":"12","author":"R Singh","year":"2005","unstructured":"Singh R, Valcarcel J. Building specificity with nonspecific RNA-binding proteins. Nat Struct Mol Biol. 2005;12(8):645\u201353.","journal-title":"Nat Struct Mol Biol"},{"issue":"5","key":"2003_CR32","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1261\/rna.036491.112","volume":"19","author":"M Hafner","year":"2013","unstructured":"Hafner M, et al. Identification of mRNAs bound and regulated by human LIN28 proteins and molecular requirements for RNA recognition. RNA. 2013;19(5):613\u201326.","journal-title":"RNA"},{"issue":"7","key":"2003_CR33","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.4161\/rna.25194","volume":"10","author":"R Graf","year":"2013","unstructured":"Graf R, et al. Identification of LIN28B-bound mRNAs reveals features of target recognition and regulation. RNA Biol. 2013;10(7):1146\u201359.","journal-title":"RNA Biol"},{"issue":"2","key":"2003_CR34","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.molcel.2018.10.041","volume":"73","author":"FE Tan","year":"2019","unstructured":"Tan FE, et al. A transcriptome-wide translational program defined by LIN28B expression level. Mol Cell. 2019;73(2):304\u201313.","journal-title":"Mol Cell"},{"issue":"5872","key":"2003_CR35","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.1154040","volume":"320","author":"SR Viswanathan","year":"2008","unstructured":"Viswanathan SR, Daley GQ, Gregory RI. Selective blockade of microRNA processing by Lin28. Science. 2008;320(5872):97\u2013100.","journal-title":"Science"},{"issue":"10","key":"2003_CR36","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.tcb.2008.07.007","volume":"18","author":"S Roush","year":"2008","unstructured":"Roush S, Slack FJ. The let-7 family of microRNAs. Trends Cell Biol. 2008;18(10):505\u201316.","journal-title":"Trends Cell Biol"},{"key":"2003_CR37","doi-asserted-by":"publisher","first-page":"1592193","DOI":"10.3389\/fonc.2025.1592193","volume":"15","author":"Y Diao","year":"2025","unstructured":"Diao Y, et al. LIN28B promotes the progression of endometrial cancer through upregulating MYC and correlates with immune microenvironment. Front Oncol. 2025;15:1592193.","journal-title":"Front Oncol"},{"issue":"2","key":"2003_CR38","doi-asserted-by":"publisher","first-page":"e3001138","DOI":"10.1371\/journal.pbio.3001138","volume":"19","author":"SA Head","year":"2021","unstructured":"Head SA, et al. Silencing of SRRM4 suppresses microexon inclusion and promotes tumor growth across cancers. PLoS Biol. 2021;19(2):e3001138.","journal-title":"PLoS Biol"},{"issue":"2","key":"2003_CR39","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/neuonc\/noad175","volume":"26","author":"K Deshpande","year":"2024","unstructured":"Deshpande K, et al. SRRM4-mediated REST to REST4 dysregulation promotes tumor growth and neural adaptation in breast cancer leading to brain metastasis. Neuro Oncol. 2024;26(2):309\u201322.","journal-title":"Neuro Oncol"},{"issue":"1","key":"2003_CR40","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s13046-024-03113-9","volume":"43","author":"G Shu","year":"2024","unstructured":"Shu G, et al. N 6 -methyladenosine modification of circMARK2 enhances cytoplasmic export and stabilizes LIN28B, contributing to the progression of Wilms tumor. J Exp Clin Cancer Res. 2024;43(1):191.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"2003_CR41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13578-024-01337-y","volume":"15","author":"B Liu","year":"2025","unstructured":"Liu B, et al. Spatial deconvolution from bulk DNA methylation profiles determines intratumoral epigenetic heterogeneity. Cell Biosci. 2025;15(1):7.","journal-title":"Cell Biosci"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-025-02003-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-025-02003-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-025-02003-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T16:20:50Z","timestamp":1763137250000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-025-02003-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2003"],"URL":"https:\/\/doi.org\/10.1186\/s13148-025-02003-x","relation":{},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"11 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"TCGA belongs to a public database. The patients included in the database have received ethical approval. Our research is based on open-source data, so there are no ethical issues. All human studies involved in our research are entirely derived from public databases and anonymous information, and all experiments conducted comply with the regulations set by the Ethics Committee of Guilin People's Hospital (Approval Number: 2024-246KY).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All the authors declare no competing fnancing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"188"}}